Evidence map›Paper›PMID 40227736›Full record

ArticleCancers2025

Fluid-Suppressed Amide Proton Transfer-Weighted Imaging Outperforms Leakage-Corrected Dynamic Susceptibility Contrast Perfusion in Distinguishing Progression from Radionecrosis in Brain Metastases.

Lucia Nichelli, Stefano Casagranda, Ottavia Dipasquale, Mehdi Bensemain, Christos Papageorgakis, Mauro Zucchelli, Julian Jacob, Charles Valery, Bertrand Mathon, Patrick Liebig and 2 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lucia NichelliParis Brain Institute (PBI)-Institut du Cerveau (ICM), Sorbonne University, Inserm UMR S 1127, CNRS 7225, F-75013 Paris, France.ORCID 0009-0006-0934-5365
Stefano CasagrandaDepartment of R&D Advanced Applications, Olea Medical, 13600 La Ciotat, France.
Ottavia DipasqualeDepartment of R&D Advanced Applications, Olea Medical, 13600 La Ciotat, France.ORCID 0000-0002-2867-8222
Mehdi BensemainDepartment of Neuroradiology, La Pitié Salpêtrière Hospital, AP-HP Sorbonne University, F-75013 Paris, France.
Christos PapageorgakisDepartment of R&D Advanced Applications, Olea Medical, 13600 La Ciotat, France.
Mauro ZucchelliDepartment of R&D Advanced Applications, Olea Medical, 13600 La Ciotat, France.
Julian JacobDepartment of Radiation-Oncology, La Pitié Salpêtrière Hospital, AP-HP Sorbonne University, F-75013 Paris, France.
Charles ValeryDepartment of Neurosurgery, La Pitié Salpêtrière Hospital, AP-HP Sorbonne University, F-75013 Paris, France.
Bertrand MathonParis Brain Institute (PBI)-Institut du Cerveau (ICM), Sorbonne University, Inserm UMR S 1127, CNRS 7225, F-75013 Paris, France.ORCID 0000-0002-9182-5846
Patrick LiebigSiemens Healthineers AG, 91301 Erlangen, Germany.ORCID 0000-0001-7342-3715
Moritz ZaissDepartment of Neuroradiology, Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.ORCID 0000-0001-9780-3616
Stéphane LehéricyParis Brain Institute (PBI)-Institut du Cerveau (ICM), Sorbonne University, Inserm UMR S 1127, CNRS 7225, F-75013 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

APTw imagingbrain metastasisCESTfluid suppressionMTRasymradionecrosis

Identifiers

PMID40227736
PMCPMC11987914

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.